Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
---|---|
pe ratio | -13.76 |
peg ratio | -0.14 |
price to book ratio | -27.16 |
price to sales ratio | 1.41 |
enterprise value multiple | 2.52 |
price fair value | -27.16 |
profitability ratios | |
---|---|
gross profit margin | 35.34% |
operating profit margin | 7.0% |
pretax profit margin | -4.59% |
net profit margin | -6.88% |
return on assets | -5.33% |
return on equity | 378.68% |
return on capital employed | 7.94% |
liquidity ratio | |
---|---|
current ratio | 1.38 |
quick ratio | 0.84 |
cash ratio | 0.07 |
efficiency ratio | |
---|---|
days of inventory outstanding | 125.60 |
operating cycle | 227.47 |
days of payables outstanding | 49.49 |
cash conversion cycle | 177.97 |
receivables turnover | 3.58 |
payables turnover | 7.37 |
inventory turnover | 2.91 |
debt and solvency ratios | |
---|---|
debt ratio | 0.76 |
debt equity ratio | -28.31 |
long term debt to capitalization | 1.05 |
total debt to capitalization | 1.04 |
interest coverage | 0.73 |
cash flow to debt ratio | 0.12 |
cash flow ratios | |
---|---|
free cash flow per share | 0.74 |
cash per share | 0.24 |
operating cash flow per share | 1.01 |
free cash flow operating cash flow ratio | 0.73 |
cash flow coverage ratios | 0.12 |
short term coverage ratios | 0.86 |
capital expenditure coverage ratio | 3.74 |
Frequently Asked Questions
Amneal Pharmaceuticals, Inc. (AMRX) published its most recent earnings results on 12-11-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Amneal Pharmaceuticals, Inc. (NYSE:AMRX)'s trailing twelve months ROE is 378.68%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Amneal Pharmaceuticals, Inc. (AMRX) currently has a ROA of -5.33%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
AMRX reported a profit margin of -6.88% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.38 in the most recent quarter. The quick ratio stood at 0.84, with a Debt/Eq ratio of -28.31.